At what gestational age can a formal fetal heart tracing (cardiotocography) be performed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fetal Heart Tracing (Cardiotocography) Gestational Age Timing

Formal cardiotocography (CTG) for fetal heart rate monitoring can be reliably performed starting at 32 weeks gestation, though the technique becomes increasingly accurate from 20 weeks onward as fetal heart rate patterns mature and the association between fetal movements and heart rate changes strengthens. 1, 2, 3

Gestational Age-Specific Capabilities

First Trimester (6-13 weeks)

  • Cardiac activity detection (not formal tracing) begins at 6 weeks using transvaginal ultrasound, which remains the gold standard for first-trimester cardiac assessment 1
  • Doppler auscultation can detect fetal heart rate transvaginally as early as 6 weeks, with successful detection in 60.5% of pregnancies at 8-9 weeks and 87.5% at 9-10 weeks 4
  • Transabdominal Doppler becomes reliable by 11-14 weeks gestation for routine heart rate assessment 1
  • Clinical auscultation achieves 80% sensitivity after 12+1 weeks and 90% sensitivity after 13 weeks 5

Second Trimester (14-27 weeks)

  • Fetal heart rate patterns begin to emerge at 20-22 weeks, though they differ significantly from mature patterns 3
  • At 20-22 weeks, 97.1% of fetal heart rate changes are decelerations (not accelerations), and 62.4% are associated with fetal movements 3
  • Formal CTG monitoring is technically possible from 20 weeks but interpretation requires different criteria than later pregnancy 3

Third Trimester (≥28 weeks)

  • By 28-30 weeks, fetal heart rate patterns mature substantially: only 33.9% of changes are decelerations, while 35.8% are accelerations and 30.3% are mixed patterns 3
  • The association between fetal movements and heart rate changes strengthens to 89.7% by 28-30 weeks 3
  • From 32 weeks onward, fetal ECG technology can reliably detect precise cardiac time intervals and QRS signals, making formal electronic fetal monitoring fully reliable 2

Critical Clinical Caveats

Pattern Interpretation Changes with Gestational Age

  • Before 30 weeks, fetal heart rate decelerations are physiologically normal and common, unlike in term pregnancies where they may indicate compromise 3
  • Standard nonstress test criteria (reactive vs non-reactive) developed for term pregnancies cannot be applied before 30 weeks without modification 3
  • The frequency of accelerations increases and decelerations decrease as gestation advances from 20 to 30 weeks 3

Technical Limitations

  • Routine antenatal fetal heart rate testing in low-risk pregnancies has no convincing evidence of improving perinatal outcomes and may lead to unnecessary interventions 1
  • False-positive results in low-risk pregnancies increase the risk of unnecessary cesarean delivery or complications from premature delivery 1

Practical Algorithm for FHT Timing

For routine low-risk pregnancy:

  • Do not perform formal CTG monitoring before 32 weeks 1, 2
  • Reserve continuous electronic fetal monitoring for high-risk indications only 1

For high-risk pregnancy requiring early monitoring:

  • Use modified interpretation criteria if monitoring between 20-30 weeks, recognizing that decelerations are physiologic 3
  • Expect predominantly deceleration patterns before 28 weeks 3
  • Apply standard reactive/non-reactive criteria only after 32 weeks 2, 3

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.